Literature DB >> 16574493

Age-dependent effects on redox status, oxidative stress, mitochondrial activity and toxicity induced by fluoroquinolones on primary cultures of rabbit tendon cells.

F Pouzaud1, M Dutot, C Martin, M Debray, J M Warnet, P Rat.   

Abstract

The age-related difference in fluoroquinolone-induced tendon toxicity was investigated. In vitro tendon cells from juvenile and young adult rabbits, respectively, were incubated with quinolone (nalidixic acid, NA) or fluoroquinolone (ofloxacin, OFX or pefloxacin, PEF) at 0.01 microM to 1 mM for 72 h. Redox status, glutathione (GSH), reactive oxygen species (ROS), and mitochondrial activity were assessed using intracellular fluorescent probes. Fluorescence signal was detected on living adherent tenocytes in microplates using cold-light cytofluorometry. Tendon toxicity differed significantly between the two cell groups and the difference was greatest with highest dose (1 mM). For 72 h, significant (p < 0.001) differences between immature and young adult primary tenocytes were observed for redox status decrease, GSH decrease, and ROS production increase. Mitochondrial activity remained unaltered in immature tenocytes. We confirm two groups of intrinsic tendon toxicity (OFX/NA vs. PEF) associated to oxidative stress (GSH decrease). Our in vitro experimental model confirms the clinical observations of age dependent tenotoxicity. First group (NA, OFX) showed greater intrinsic tenotoxicity for young adult than immature tenocytes, second group (PEF) was highly toxic for immature and young adult cells. The three quinolones do not altered mitochondrial activity in immature tenocytes whereas alteration was observed in young adult tenocytes.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16574493     DOI: 10.1016/j.cbpc.2006.02.006

Source DB:  PubMed          Journal:  Comp Biochem Physiol C Toxicol Pharmacol        ISSN: 1532-0456            Impact factor:   3.228


  8 in total

1.  Fluoroquinolone-induced serious, persistent, multisymptom adverse effects.

Authors:  Beatrice Alexandra Golomb; Hayley Jean Koslik; Alan J Redd
Journal:  BMJ Case Rep       Date:  2015-10-05

Review 2.  Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components.

Authors:  Alison E Barnhill; Matt T Brewer; Steve A Carlson
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

3.  Effect of Ciprofloxacin on Susceptibility to Aortic Dissection and Rupture in Mice.

Authors:  Scott A LeMaire; Lin Zhang; Wei Luo; Pingping Ren; Alon R Azares; Yidan Wang; Chen Zhang; Joseph S Coselli; Ying H Shen
Journal:  JAMA Surg       Date:  2018-09-19       Impact factor: 14.766

Review 4.  Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism.

Authors:  Beatrice A Golomb; Marcella A Evans
Journal:  Am J Cardiovasc Drugs       Date:  2008       Impact factor: 3.571

Review 5.  Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications.

Authors:  Krzysztof Michalak; Aleksandra Sobolewska-Włodarczyk; Marcin Włodarczyk; Justyna Sobolewska; Piotr Woźniak; Bogusław Sobolewski
Journal:  Oxid Med Cell Longev       Date:  2017-09-25       Impact factor: 6.543

6.  JEG-3 placental cells in toxicology studies: a promising tool to reveal pregnancy disorders.

Authors:  Elodie Olivier; Anaïs Wakx; Sophie Fouyet; Mélody Dutot; Patrice Rat
Journal:  Anat Cell Biol       Date:  2021-03-31

Review 7.  Roles of Oxidative Stress in Acute Tendon Injury and Degenerative Tendinopathy-A Target for Intervention.

Authors:  Pauline Po Yee Lui; Xing Zhang; Shiyi Yao; Haonan Sun; Caihao Huang
Journal:  Int J Mol Sci       Date:  2022-03-25       Impact factor: 5.923

8.  Ciprofloxacin impairs mitochondrial DNA replication initiation through inhibition of Topoisomerase 2.

Authors:  Anu Hangas; Koit Aasumets; Nina J Kekäläinen; Mika Paloheinä; Jaakko L Pohjoismäki; Joachim M Gerhold; Steffi Goffart
Journal:  Nucleic Acids Res       Date:  2018-10-12       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.